ArticleFrontiers in oncology2026

Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinoma.

Anna M Reagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.